Abstract
Background The coronavirus disease 2019 (COVID-19) is a widespread, highly contagious inflammatory process that causes respiratory, physical and psychological dysfunction. COVID-19 mainly affects the respiratory system and evolves in the acute phase from mild cases with common symptoms, such as fever, cough, and fatigue, to the moderate-to-severe form, causing massive alveolar damage resulting in dyspnea and hypoxemia that can rapidly progress to pneumonia, and acute respiratory distress syndrome. The acute form usually causes severe pulmonary sequelae such as pulmonary fibrosis or progression to organ failure, leading to worsening metabolic dysfunction and/or death.
Purpose To verify the effects of an outpatient and home pulmonary rehabilitation program (PRP) on clinical symptoms, pulmonary function, physical activity level, functional status, autonomic activity, peripheral muscle strength, static and functional balance, functional mobility, anxiety and depression, post-traumatic stress, health-related quality of life, and survival of patients with sequelae from COVID-19.
Methods This study will be a cohort, parallel, two-arm multicentric study, to be carried out in three clinical centers, with blind evaluation, with 06 weeks of training and follow-up. This study was designed according to the recommendations of the CONSORT statement. To be involved in this clinical study, according to the inclusion criteria, women and men aged between 16 and 75 years affected by COVID-19. The proposed PRP is based on the guidelines recommended by the Global Initiative for Chronic Obstructive Lung Disease and, consists of a combination of aerobic and muscle strengthening exercises, lasting six weeks, with a frequency of three times a week.
Discussion In patients infected with COVID-19 with persistent symptoms and sequelae, PRP mainly seeks to improve dyspnea, relieve anxiety and depression, prevent, and reduce complications and/or dysfunctions, reduce morbidity and mortality, and improve health-related quality of life.
Trial registration This study was registered at clinicaltrials.gov (ID: COVID-19 PULMONARY REHAB NCT04982042).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov (ID: COVID-19 PULMONARY REHAB - NCT04982042).
Funding Statement
The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures to be performed with the patients involved in this study are in accordance with international ethical standards for research involving human beings as per the 1964 Declaration of Helsinki and its subsequent amendments. This research protocol was approved by the Ethics Committee for Research with Human Beings of the Evangelical University of Goiás (UNIEVANGÉLICA) under protocol number 4.235.203. This clinical trial is registered at ClinicalTrials.gov (ID: COVID-19 PULMONARY REHAB - NCT04982042). Involvement in the study will be voluntary, and leave is allowed at any time without any burden. Participants will be required to sign the Informed Consent Form after receiving all information about the Pulmonary Rehabilitation Program.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
Funding This study protocol was approved in an emergency public call from the government of the State of Goiás (Brazil): Public Call: 06/2020 - Mapping of Proposals to Address Covid-19. Administrative process no.: 202010267000277. Research project: “COVID-19 Outpatient and Home Pulmonary Rehabilitation Program” from the Goiás State Research Support Foundation - FAPEG, Brazil. The full name of the funder is: Fundação de Amparo a Pesquisa do Estado de Goiás – FAPEG, Goiania (GO), Brazil. Website: http://www.fapeg.go.gov.br. The authors thank Evangelical University of Goiás - UniEVANGÉLICA for the partial support to the development of this research. The funders had and will not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding letter has been attached as a supporting file.
ASS receives grants of Coordenaçao de Apoio ao Pessoal de Nível Superior (CAPES/PROSUP); JPRA and RSM receives grants of Fundação de Amparo a Pesquisa (FAPEG), Goiás (GO), Brazil; LVFO receive grants Research Productivity, modality PQ1D; process no. 312731/2018-3 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq), Brazil. RPV receive grants Research Productivity, modality PQII; process no. 313299/2018-8 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq), Brazil. CSO receive grants Research Productivity, modality PQII; process no. 310904/2021-8 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq), Brazil. RABLM receive grants Research Productivity, modality PQ1D; process no. 309920/2019-1 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq), Brazil. GCJ receive grants Research Productivity, modality PQII; process no. 315604/2021-2 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (local acronym CNPq), Brazil. GI is a senior researcher at the Institute for Biomedical Research and Innovation, National Research Council - CNR, Palermo (SI), Italy.
Competing interests The authors have declared that no competing interests exist.
Data AvailabilityStatement All relevant data from this study will be made available upon study completion.
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
https://www4.unievangelica.edu.br/ppg/movimento-humano-e-reabilitacao
